The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population.

Though they were developed for depression ... inhibitors (SNRIs), which include venlafaxine (Effexor) and duloxetine (Cymbalta). These drugs act on brain chemicals called neurotransmitters ...

Add videos to your saved list and come back to them any time.

The Los Angeles fires have forced thousands to evacuate indefinitely from their homes, often without necessary medications or medical devices. Here’s what to do if you find yourself without ...

These include existing drugs Pregabalin, used for chronic pain, and Modafinil, used for narcolepsy, being repurposed for the treatment of depression. However, they warned that further studies ...

A Queensland scientist described the project as the world’s largest study "looking at the genetics of depression". The research suggests existing anti-cancer therapies and medications used to ...

Lexapro (escitalopram) has potential interactions with other medications ... and venlafaxine (Effexor XR). Lexapro is used to treat major depressive disorder (depression) in adults and certain ...

And, beyond medication, identifying individuals with a higher genetic risk of developing depression could be preemptively armed with specific techniques to better manage stressors – one of the ...

Graham, also from West Yorkshire, said he had been paying less than £100 a month for his ADHD medication since going private four months ago after being diagnosed with severe depression and ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being developed in Hamilton after a McMaster University researcher discovered a new ...

Rublev was quick to add that his decision to not take medication may not be the right one for others who suffer from depression. 'You can have everything in life, a healthy family, all the ...

The chief prize in buying Intra-Cellular is a medicine known as Caplyta that’s approved in the U.S. to treat schizophrenia and bipolar depression. The biotech recently asked the Food and Drug ...